FDA Regional Field Office XII - Soccsksargen

06/08/2026

06/08/2026

****FDA Advisory No.2026-0856 || PRODUCT RECALL OF AFFECTED STOCKS OF BEAUTY WHITE FACIAL TONER DUE TO THE PRESENCE OF TRETINOIN AND HYDROQUINONE****

The Food and Drug Administration (FDA) hereby informs all healthcare professionals and the general public regarding the recall of batch/lot number no. YGRT 260203 of the cosmetic product Beauty White Facial Toner by the marketing authorization holder (MAH), You Glow Babe Skin Care Product Trading OPC.

As part of the post-marketing surveillance (PMS) activities of the FDA, the aforementioned cosmetic product was collected and tested and, upon laboratory analysis, was found to contain the banned ingredients Tretinoin and Hydroquinone.

See more:-> https://tinyurl.com/juy4bbmx

06/08/2026

****FDA Advisory No.2026-0858 || PRODUCT RECALL OF AFFECTED STOCKS OF BEAUTY LOVE SKIN ESSENTIALS REJUVENATING FACIAL TONER DUE TO THE PRESENCE OF TRETINOIN AND HYDROQUINONE****

The Food and Drug Administration (FDA) hereby informs all healthcare professionals and the general public regarding the recall of batch/lot number no. BLT260301 of the cosmetic product Beauty Love Skin Essentials Rejuvenating Facial Toner by the marketing authorization holder (MAH), KCN Enterprises.

See more:-> https://tinyurl.com/7y2mm4k2

06/08/2026

****FDA Advisory No.2022-1214-A || Lifting the Advisory on the Notified Cosmetic Product “BYS LIQUID FOUNDATION VARIANT-MEDIUM” under FDA Advisory No. 2022-1214 “Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic BYS LIQUID FOUNDATION VARIANT-MEDIUM dated 27 June 2022****

The Food and Drug Administration (FDA) informs all healthcare professionals and the general public that the cosmetic product BYS LIQUID FOUNDATION VARIANT-MEDIUM has been notified by the Market Authorization Holder, IFACE INC. with Notification No. 1000016199865 in accordance with existing FDA rules and regulations.

Accordingly, the warning against the purchase and use of the subject product as mentioned in FDA Advisory No. 2022-1214 dated 27 June 2022 and its corresponding FDA Order is hereby lifted.

Read more:-> https://tinyurl.com/bd2cbb96

06/08/2026

****FDA Advisory No.2022-1688-A || Lifting the Advisory on the Notified Cosmetic Product “DEOPROCE LAP THERAPY SWALLOWS NEST AQUA MASK PACK” under FDA Advisory No. 2022-1688 “Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic “DEOPROCE LAP THERAPY SWALLOW’S NEST AQUA MASK PACK” dated 03 October 2022****

Read more:-> https://tinyurl.com/3ukbpbve

06/08/2026

****FDA Advisory No.2022-2067-A || Lifting the Advisory on the Notified Cosmetic Product “SOME BY MI REAL TEATREE CALMING CARE MASK” under FDA Advisory No. 2022-2067 “Public Health Warning Against the Purchase and Use of Unauthorized Cosmetic “SOME BY MI REAL TEATREE CALMING CARE MASK dated 16 December 2022****

The Food and Drug Administration (FDA) informs all healthcare professionals and the general public that the cosmetic product SOME BY MI REAL TEATREE CALMING CARE MASK has been notified by the Market Authorization Holder, Kohl Industries Corporation, with Notification No. 1000015800973 in accordance with existing FDA rules and regulations.

Accordingly, the warning against the purchase and use of the subject product as mentioned in FDA Advisory No. 2022-2067 dated 16 December 2022 and its corresponding FDA Order is hereby lifted.

Read more:-> https://tinyurl.com/ympzh82n

06/08/2026

****FDA Advisory No.2026-0857 || PRODUCT RECALL OF AFFECTED STOCKS OF BEAUTY LOVE SKIN ESSENTIALS REJUVENATING NIGHT CREAM DUE TO THE PRESENCE OF TRETINOIN AND HYDROQUINONE****

The Food and Drug Administration (FDA) hereby informs all healthcare professionals and the general public regarding the recall of batch/lot number no. BLRC260202 of the cosmetic product Beauty Love Skin Essentials Rejuvenating Night Cream by the marketing authorization holder (MAH), KCN Enterprises

As part of the post-marketing surveillance (PMS) activities of the FDA, the aforementioned cosmetic product was collected and tested and, upon laboratory analysis, was found to contain the banned ingredients Tretinoin and Hydroquinone.

Read more:-> https://tinyurl.com/32s3ur2z

06/08/2026

****FDA Advisory No.2021-0819-A || Lifting the Advisory on the Notified Cosmetic Product “DEOPROCE COLOR SYNERGY EFFECT SHEET MASK YELLOW” under FDA Advisory No. 2021-0819 “Public Health Warning Against the Purchase and Use of the Non-Compliant Cosmetic Product “DEOPROCE COLOR SYNERGY EFFECT SHEET MASK YELLOW” dated 21 April 2021****

The Food and Drug Administration (FDA) informs all healthcare professionals and the general public that the cosmetic product DEOPROCE COLOR SYNERGY EFFECT SHEET MASK YELLOW has been notified by the Market Authorization Holder, ZFACE INC. with Notification No. 1000015774054 in accordance with existing FDA rules and regulations.

Accordingly, the warning against the purchase and use of the subject product as mentioned in FDA Advisory No. 2021-0819 dated 21 April 2021 and its corresponding FDA Order is hereby lifted.

Read more:-> https://tinyurl.com/26mtf9r6

06/08/2026

Webinar on Licensing of Pest Control Operator Establishments (LS-PCO)

This webinar is intended for all Pest Control Operators (PCO) engaged in the business of household/urban pesticides (HUP) or any other methods/services for pest control. Participants may be owners/ general managers/ authorized representatives of PCO establishments, as well as supervising pesticide handlers, and pesticide handlers.
It aims to provide knowledge to the stakeholders on DOH A.O. No. 2019-0010 or the implementing guidelines on the Issuance of a License to Operate (LTO) as a Household/Urban Pest Control Operator.
Topics include LTO requirements, demonstration of LTO application as a PCO establishment via the FDA eServices Portal, inspection requirements and responsibilities of PCO establishments, supervising pesticide handlers, and pesticide handlers among others.

Join our free webinar on 09 September 2026 from 8:00 am to 12:00 nn via Google Meet
Register through this link: bit.ly/4xmRvSR

Maximum of 500 participants
First-come-first-served basis

All successful registrants/applicants shall wait for the confirmation email from the FDA Academy for the issuance of Course Assessment Slip (CAS) and payment instruction pursuant to FDA Circular 2023-010.

Payments made without the corresponding CAS from the FDA Academy shall be forfeited.

06/08/2026

Training on the Registration Process and Post-Approval Changes of Pharmaceutical Products for Human Use by the Center for Drug Regulation and Research (CDRR)

This three-day training will provide detailed discussions on the technical requirements and procedures on the issuance of Certificate of Product Registration (CPR) including Post-Approval Changes of pharmaceutical products for human use.

Join our face-to-face training on 09-11 September 2026 from 8:00 am to 5:00 pm

Venue: Vivere Hotel, Alabang, Muntinlupa City
Registration fee: Php 8,500.00
Register through this link: bit.ly/4w1xnV6

Maximum of 70 participants
First-come-first served basis

All successful registrants/applicants shall wait for the confirmation email from the FDA Academy for the issuance of Course Assessment Slip (CAS) and payment instruction pursuant to FDA Circular 2023-010.

Payments made without the corresponding CAS from the FDA Academy shall be forfeited.